Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
Atherosclerosis ; 221(1): 268-74, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22257824

RESUMEN

Chylomicron remnants bind to both their specific receptors (LRP) and to the LDL receptor (LDLR) in the liver. There is controversy whether disturbances of chylomicron metabolism occur in subjects with familial hypercholesterolemia (FH). The aim of this study was to evaluate whether there are defects on the removal from plasma of chylomicrons and their remnants in heterozygous FH patients with determined LDLR mutations. We studied 20 heterozygous FH patients (43.2±12 years old, 60% males) and 50 normolipidemic subjects matched for age and gender. FH subjects were not in use of LDL-lowering drugs for at least 6 weeks. The removal from plasma of chylomicrons and their remnants was measured by isotopic decay after venous injection of a chylomicron-like emulsion radiolabeled with (14)C-cholesteryl ester ((14)C-CE) and (3)H-triolein ((3)H-TO). These track respectively removal from plasma of chylomicrons and remnants and lipolysis. There was a significant reduction in the fractional catabolic rates (FCR in h(-1)) of (14)C-CE in FH in comparison with normolipidemics: 0.048 (1.46.10(-7); 0.57) vs. 0.71(0.049; 1.62), [median (25th-75th percentile)], p=0.003. No differences were found in FCR of (3)H-TO between FH and controls, respectively 1.62 (1.02; 2.331) and 1.914 (1.34; 2.878), p=0.405. In conclusion heterozygous FH subjects had a significant decrease on the removal from plasma of chylomicrons and their remnants compared with normolipidemics.


Asunto(s)
Remanentes de Quilomicrones/sangre , Quilomicrones/sangre , Heterocigoto , Hiperlipoproteinemia Tipo II/sangre , Hiperlipoproteinemia Tipo II/genética , Mutación , Receptores de LDL/genética , Adulto , Brasil , Radioisótopos de Carbono , Estudios de Casos y Controles , Distribución de Chi-Cuadrado , Ésteres del Colesterol/administración & dosificación , Ésteres del Colesterol/sangre , Ésteres del Colesterol/farmacocinética , Emulsiones , Femenino , Predisposición Genética a la Enfermedad , Humanos , Inyecciones Intravenosas , Lipólisis , Masculino , Persona de Mediana Edad , Fenotipo , Trioleína/administración & dosificación , Trioleína/farmacocinética , Tritio
2.
Braz J Med Biol Res ; 40(3): 305-7, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17334526

RESUMEN

Disorders of the lipid metabolism may play a role in the genesis of abdominal aorta aneurysm. The present study examined the intravascular catabolism of chylomicrons, the lipoproteins that carry the dietary lipids absorbed by the intestine in the circulation in patients with abdominal aorta aneurysm. Thirteen male patients (72 +/- 5 years) with abdominal aorta aneurysm with normal plasma lipid profile and 13 healthy male control subjects (73 +/- 5 years) participated in the study. The method of chylomicron-like emulsions was used to evaluate this metabolism. The emulsion labeled with 14C-cholesteryl oleate and (3)H-triolein was injected intravenously in both groups. Blood samples were taken at regular intervals over 60 min to determine the decay curves. The fractional clearance rate (FCR) of the radioactive labels was calculated by compartmental analysis. The FCR of the emulsion with (3)H-triolein was smaller in the aortic aneurysm patients than in controls (0.025 +/- 0.017 vs 0.039 +/- 0.019 min-1; P < 0.05), but the FCR of 14C-cholesteryl oleate of both groups did not differ. In conclusion, as indicated by the triglyceride FCR, chylomicron lipolysis is diminished in male patients with aortic aneurysm, whereas the remnant removal which is traced by the cholesteryl oleate FCR is not altered. The results suggest that defects in the chylomicron metabolism may represent a risk factor for development of abdominal aortic aneurysm.


Asunto(s)
Aneurisma de la Aorta Abdominal/metabolismo , Ésteres del Colesterol/farmacocinética , Quilomicrones/farmacocinética , Lipólisis , Trioleína/farmacocinética , Anciano , Aneurisma de la Aorta Abdominal/sangre , Aneurisma de la Aorta Abdominal/etiología , Índice de Masa Corporal , Radioisótopos de Carbono , Estudios de Casos y Controles , Ésteres del Colesterol/administración & dosificación , Quilomicrones/administración & dosificación , Emulsiones , Humanos , Inyecciones Intravenosas , Masculino , Tasa de Depuración Metabólica , Trioleína/administración & dosificación
3.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;40(3): 305-307, Mar. 2007.
Artículo en Inglés | LILACS | ID: lil-441770

RESUMEN

Disorders of the lipid metabolism may play a role in the genesis of abdominal aorta aneurysm. The present study examined the intravascular catabolism of chylomicrons, the lipoproteins that carry the dietary lipids absorbed by the intestine in the circulation in patients with abdominal aorta aneurysm. Thirteen male patients (72 ± 5 years) with abdominal aorta aneurysm with normal plasma lipid profile and 13 healthy male control subjects (73 ± 5 years) participated in the study. The method of chylomicron-like emulsions was used to evaluate this metabolism. The emulsion labeled with 14C-cholesteryl oleate and ³H-triolein was injected intravenously in both groups. Blood samples were taken at regular intervals over 60 min to determine the decay curves. The fractional clearance rate (FCR) of the radioactive labels was calculated by compartmental analysis. The FCR of the emulsion with ³H-triolein was smaller in the aortic aneurysm patients than in controls (0.025 ± 0.017 vs 0.039 ± 0.019 min-1; P < 0.05), but the FCR of14C-cholesteryl oleate of both groups did not differ. In conclusion, as indicated by the triglyceride FCR, chylomicron lipolysis is diminished in male patients with aortic aneurysm, whereas the remnant removal which is traced by the cholesteryl oleate FCR is not altered. The results suggest that defects in the chylomicron metabolism may represent a risk factor for development of abdominal aortic aneurysm.


Asunto(s)
Humanos , Masculino , Anciano , Aneurisma de la Aorta Abdominal/metabolismo , Ésteres del Colesterol/farmacocinética , Quilomicrones/farmacología , Lipólisis , Trioleína/farmacocinética , Aneurisma de la Aorta Abdominal/sangre , Índice de Masa Corporal , Radioisótopos de Carbono , Estudios de Casos y Controles , Ésteres del Colesterol/administración & dosificación , Quilomicrones/administración & dosificación , Emulsiones , Inyecciones Intravenosas , Tasa de Depuración Metabólica , Trioleína/administración & dosificación
4.
Atherosclerosis ; 126(1): 15-25, 1996 Sep 27.
Artículo en Inglés | MEDLINE | ID: mdl-8879430

RESUMEN

Chylomicron catabolism in the bloodstream consists of lipolysis by lipoprotein lipase and uptake of remnants by the liver. In rats, triglyceride-rich emulsions can mimic chylomicron metabolism. To further validate this model in man, the emulsion was injected intravenously into fasting and into subjects previously fed a test fatty meal. The plasma kinetic curves of the emulsion 3H-triglyceride and 14C-cholesteryl ester were determined. The fractional clearance rate (FCR) of both labels was markedly reduced in the fed subjects (triglycerides: fed = 0.018 +/- 0.007; fasting = 0.105 +/- 0.013 min-1, P < 0.001; cholesteryl ester: fed = 0.016 +/- 0.001; fasting = 0.040 +/- 0.006 min-1; P < 0.05) indicating that the emulsion and chylomicrons generated from the testinal lipid absorption compete for the same catabolic processes, confirming the validity of the method. The emulsion was injected into 11 patients with CAD and into 11 controls. All had plasma cholesterol < 240 and triglycerides < 250 mg/dl. FCR of triglycerides was 5-fold smaller in CAD compared to controls (0.028 +/- 0.004 and 0.141 +/- 0.069 min-1, respectively, P < 0.01). FCR of cholesteryl ester was 4-fold smaller in CAD than in controls (0.015 +/- 0.004 and 0.056 +/- 0.067 min-1 respectively, P < 0.05). These results indicate that both chylomicron lipolysis and remnant removal are diminished in CAD.


Asunto(s)
Ésteres del Colesterol/sangre , Ésteres del Colesterol/farmacocinética , Colesterol/farmacocinética , Quilomicrones/sangre , Enfermedad Coronaria/sangre , Glicoproteínas , Fosfatidilcolinas/farmacocinética , Triglicéridos/sangre , Trioleína/farmacocinética , Adulto , Animales , Proteínas Portadoras/sangre , Colesterol/administración & dosificación , Proteínas de Transferencia de Ésteres de Colesterol , Ésteres del Colesterol/administración & dosificación , Enfermedad Coronaria/complicaciones , Grasas de la Dieta/farmacocinética , Susceptibilidad a Enfermedades , Interacciones Farmacológicas , Emulsiones , Femenino , Humanos , Hiperlipidemias/sangre , Hiperlipidemias/complicaciones , Inyecciones Intravenosas , Absorción Intestinal , Lipoproteínas/sangre , Masculino , Persona de Mediana Edad , Fosfatidilcolinas/administración & dosificación , Ratas , Especificidad de la Especie , Trioleína/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA